Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Novel Respiratory Impedance-Based Phenotypes Reflect Different Pathophysiologies in Chronic Obstructive Pulmonary Disease Patients.

Matsuo Y, Ogawa E, Seto-Yukimura R, Ryujin Y, Kinose D, Yamaguchi M, Osawa M, Nagao T, Kurosawa H, Nakano Y.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 20;14:2971-2977. doi: 10.2147/COPD.S224902. eCollection 2019.

2.

Acute Generalized Exanthematous Pustulosis Caused by the Combination of Pembrolizumab Plus Chemotherapy in a Patient With Squamous-Cell Carcinoma.

Matsubara T, Uchi H, Haratake N, Takamori S, Toyozawa R, Miura N, Yamaguchi M, Seto T, Takenoyama M.

Clin Lung Cancer. 2019 Nov 20. pii: S1525-7304(19)30326-2. doi: 10.1016/j.cllc.2019.11.009. [Epub ahead of print] No abstract available.

PMID:
31874730
3.

Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer.

Yamaguchi M, Hirata H, Ebi N, Araki J, Seto T, Maruyama R, Akamine S, Inoue Y, Semba H, Sasaki J, Okamoto T.

Jpn J Clin Oncol. 2019 Dec 5. pii: hyz179. doi: 10.1093/jjco/hyz179. [Epub ahead of print]

PMID:
31804689
4.

Correction: Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study.

Nakagawa H, Ogawa E, Fukunaga K, Kinose D, Yamaguchi M, Nagao T, Tanaka-Mizuno S, Nakano Y.

PLoS One. 2019 Dec 2;14(12):e0226214. doi: 10.1371/journal.pone.0226214. eCollection 2019.

5.

Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab.

Ohba T, Takamori S, Toyozawa R, Nosaki K, Umeyama Y, Haratake N, Miura N, Yamaguchi M, Taguchi K, Seto T, Shimokawa M, Takenoyama M.

J Thorac Dis. 2019 Sep;11(9):3757-3768. doi: 10.21037/jtd.2019.09.29.

6.

Aeromonas sobria serine protease decreases epithelial barrier function in T84 cells and accelerates bacterial translocation across the T84 monolayer in vitro.

Kobayashi H, Seike S, Yamaguchi M, Ueda M, Takahashi E, Okamoto K, Yamanaka H.

PLoS One. 2019 Aug 16;14(8):e0221344. doi: 10.1371/journal.pone.0221344. eCollection 2019.

7.

Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients.

Haratake N, Seto T, Takamori S, Toyozawa R, Nosaki K, Miura N, Ohba T, Toyokawa G, Taguchi K, Yamaguchi M, Shimokawa M, Takenoyama M.

Thorac Cancer. 2019 Sep;10(9):1779-1787. doi: 10.1111/1759-7714.13143. Epub 2019 Jul 23.

8.

Terawatt-scale photovoltaics: Transform global energy.

Haegel NM, Atwater H Jr, Barnes T, Breyer C, Burrell A, Chiang YM, De Wolf S, Dimmler B, Feldman D, Glunz S, Goldschmidt JC, Hochschild D, Inzunza R, Kaizuka I, Kroposki B, Kurtz S, Leu S, Margolis R, Matsubara K, Metz A, Metzger WK, Morjaria M, Niki S, Nowak S, Peters IM, Philipps S, Reindl T, Richter A, Rose D, Sakurai K, Schlatmann R, Shikano M, Sinke W, Sinton R, Stanbery BJ, Topic M, Tumas W, Ueda Y, van de Lagemaat J, Verlinden P, Vetter M, Warren E, Werner M, Yamaguchi M, Bett AW.

Science. 2019 May 31;364(6443):836-838. doi: 10.1126/science.aaw1845. No abstract available.

PMID:
31147512
9.

The Influence of Clinical T Factor on Predicting Pathologic N Factor in Resected Lung Cancer.

Shimamatsu S, Takenoyama M, Shimokawa M, Takada K, Edagawa M, Toyozawa R, Nosaki K, Oba T, Tagawa T, Yamaguchi M, Taguchi K, Seto T.

Ann Thorac Surg. 2019 Oct;108(4):1080-1086. doi: 10.1016/j.athoracsur.2019.04.026. Epub 2019 May 16.

PMID:
31103386
10.

Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study.

Nakagawa H, Ogawa E, Fukunaga K, Kinose D, Yamaguchi M, Nagao T, Tanaka-Mizuno S, Nakano Y.

PLoS One. 2019 Mar 21;14(3):e0214278. doi: 10.1371/journal.pone.0214278. eCollection 2019. Erratum in: PLoS One. 2019 Dec 2;14(12):e0226214.

11.

Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?

Yamaguchi M, Shimamatsu S, Edagawa M, Hirai F, Toyozawa R, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Today. 2019 Mar;49(3):197-205. doi: 10.1007/s00595-018-1751-7. Epub 2019 Jan 4.

PMID:
30610361
12.

[I. Current Treatment Strategy for Locally Advanced Non-Small Cell Lung Cancer - From the General Thoracic Surgeons' Point of View].

Yamaguchi M.

Gan To Kagaku Ryoho. 2018 Aug;45(8):1148-1151. Japanese. No abstract available.

PMID:
30158408
13.

A case of different EGFR mutations in surgically resected synchronous triple lung cancer.

Haratake N, Takenoyama M, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y.

J Thorac Dis. 2018 Apr;10(4):E255-E259. doi: 10.21037/jtd.2018.03.105.

14.

Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.

Hira D, Koide H, Nakamura S, Okada T, Ishizeki K, Yamaguchi M, Koshiyama S, Oguma T, Ito K, Funayama S, Komase Y, Morita SY, Nishiguchi K, Nakano Y, Terada T.

PLoS One. 2018 Feb 20;13(2):e0193082. doi: 10.1371/journal.pone.0193082. eCollection 2018.

15.

A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report.

Yamaguchi M, Hirai F, Taguchi K, Toyozawa R, Edagawa M, Shimamatsu S, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Case Rep. 2017 Oct 4;3(1):108. doi: 10.1186/s40792-017-0382-3.

16.

Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis.

Uchida Y, Tsugawa T, Tanaka-Mizuno S, Noma K, Aoki K, Shigemori W, Nakagawa H, Kinose D, Yamaguchi M, Osawa M, Ogawa E, Nakano Y.

Radiat Oncol. 2017 Oct 2;12(1):160. doi: 10.1186/s13014-017-0891-z.

17.

Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case report.

Edagawa M, Haratake N, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Kaneko K, Seto T, Takenoyama M, Ichinose Y.

J Thorac Dis. 2017 Aug;9(8):E689-E693. doi: 10.21037/jtd.2017.07.90.

18.

Does lung cancer surgery cause circulating tumor cells?-A multicenter, prospective study.

Matsutani N, Sawabata N, Yamaguchi M, Woo T, Kudo Y, Kawase A, Shiono S, Iinuma H, Morita S, Kawamura M.

J Thorac Dis. 2017 Aug;9(8):2419-2426. doi: 10.21037/jtd.2017.07.33.

19.

Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type.

Hirai F, Edagawa M, Shimamatsu S, Toyozawa R, Toyokawa G, Nosaki K, Yamaguchi M, Seto T, Takenoyama M, Ichinose Y.

Oncol Lett. 2017 Jul;14(1):306-312. doi: 10.3892/ol.2017.6118. Epub 2017 May 4.

20.

Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report.

Takamori S, Yamaguchi M, Taguchi K, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Seto T, Takenoyama M, Ichinose Y.

Surg Case Rep. 2017 Dec;3(1):46. doi: 10.1186/s40792-017-0322-2. Epub 2017 Mar 20.

Supplemental Content

Loading ...
Support Center